Madrigal Pharmaceuticals Inc share price logo

Madrigal Pharmaceuticals Inc

NASDAQ: MDGL

Large Cap

$513.66

-3.73

(-0.72%)

as on

Madrigal Pharmaceuticals Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $504.00
    $520.77
    downward going graph

    1.88%

    Downside

    1.38%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $265.00
    $615.00
    downward going graph

    48.41%

    Downside

    19.73%

    Upside

    downward going graph

Madrigal Pharmaceuticals Inc share price movements today

Previous Close
$517.39
Open
$517.04
Volume
248.7K
Day's Low - High
$504.00 - $520.77
52 Week Low - High
$265.00 - $615.00

Madrigal Pharmaceuticals Inc Historical Returns

1 Month Return
-6.07 %
3 Month Return
+ 4.9 %
1 Year Return
+ 62.84 %
3 Year Return
+ 69.54 %
5 Year Return
+ 277.46 %

Madrigal Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Madrigal Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.9B

EPS (TTM)

-5.782

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-298.6M

Revenue (TTM)

958.4M

Profit Margin

-30.08%

Return On Equity TTM

-42.49%

Madrigal Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Madrigal Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$11.9B277.46%NA-30.08%
BUY$41.3B110.54%77.5712.55%
BUY$108.7B94.28%27.9332.94%
NA$32.7BNA118.495.37%
BUY$74.1B45.73%17.2729.65%

Stock Returns calculator for Madrigal Pharmaceuticals Inc Stock including INR - Dollar returns

The Madrigal Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Madrigal Pharmaceuticals Inc investment value today

Current value as on today

₹1,82,820

Returns

₹82,820

(+82.82%)

Returns from Madrigal Pharmaceuticals Inc Stock

₹62,819 (+62.82%)

Dollar Impact

₹20,001 (+20%)

Analyst Recommendation on Madrigal Pharmaceuticals Inc Stock

Based on 21 analysts

BUY

80.95%

Buy

14.29%

Hold

4.76%

Sell

Based on 21 analysts, 80.95% of analysts recommend a 'BUY' rating for Madrigal Pharmaceuticals Inc. Average target price of $672.79

Madrigal Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Madrigal Pharmaceuticals Inc.

What analysts predicted

23.65%UPSIDE

Target Price

$672.79

Current Price

$513.66

Analyzed by

21 Analysts

Target

$672.79

Madrigal Pharmaceuticals Inc target price $672.79, a slight upside of 23.65% compared to current price of $513.66. According to 21 analysts rating.

Madrigal Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Madrigal Pharmaceuticals Inc Stock has increased by 119% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:119% versus previous 30 day period

Madrigal Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
14
62
103
137
212
287
321
Gross Profit
0
0
0
14
60
99
132
203
269
296
Operating Income
-98
-117
-152
-162
-116
-66
-79
-47
-113
-59
EBITDA
-95
-108
-143
-148
-102
-55
-69
-38
-106
-49
Interest Expense
3
3
3
3
3
3
3
3
7
8
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-98
-112
-147
-151
-106
-59
-73
-42
-114
-58
Income Tax Expense
0
0
0
-
0
-
-
-
-
-
Net Income
-98
-112
-147
-151
-106
-59
-73
-42
-114
-58
Net Profit Margin
0.00%
-14570.65%
0.00%
-1038.20%
-172.04%
-57.51%
-53.36%
-19.87%
-39.75%
-18.24%

Madrigal Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
-
0
0
-
-
180
958
Gross Profit
0
0
0
0
0
0
0
0
173
902
Operating Income
-25
-32
-40
-94
-206
-242
-293
-380
-497
-300
EBITDA
-25
-31
-40
-94
-206
-242
-290
-360
-450
-264
Interest Expense
1
0
7
11
4
1
3
12
14
22
Depreciation
-
0
0
0
0
0
0
0
1
1
Income Before Tax
-26
-31
-32
-83
-202
-241
-295
-373
-465
-288
Income Tax Expense
0
0
7
-11
-4
0
3
-
-465
-
Net Income
-26
-31
-32
-72
-197
-241
-295
-373
-465
-288
Net Profit Margin
0.00%
-8901.14%
-16405.50%
0.00%
-903055.25%
-646009.97%
0.00%
0.00%
-258.64%
-30.08%

Madrigal Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-112
-147
-151
-106
-59
-73
-42
-114
-58
Operating Cash Flow
-79
-149
-134
-66
-104
-88
-47
79
-133
Investing Cash Flow
-362
98
-122
-202
-47
163
47
-206
27
Financing Cash Flow
479
573
134
7
19
8
1
236
8
Change in Cash
37
522
-122
-261
-132
83
2
109
-96

Madrigal Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-32
-83
-202
-241
-295
-373
-465
-288
Operating Cash Flow
-22
-25
-41
-157
-183
-224
-324
-455
-189
Investing Cash Flow
-22
-380
30
159
-5
206
-502
-274
32
Financing Cash Flow
173
314
0
5
171
313
595
735
255
Change in Cash
129
-91
-10
7
-17
295
-231
5
98

Global Institutional Holdings in Madrigal Pharmaceuticals Inc

Funds
Holdings
FMR Inc
1.92%
Lord, Abbett & Co LLC
1.07%
The Goldman Sachs Group Inc
1.68%
Amvescap Plc.
1.31%
HHG PLC
6.91%

Insights on Madrigal Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MDGL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MDGL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, MDGL stock has moved down by -6.1%

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
OrganisationMadrigal Pharmaceuticals Inc
HeadquartersFour Tower Bridge, West Conshohocken, PA, United States, 19428
IndustryBiotechnology
CEOMr. William J. Sibold
E-voting on sharesClick here to vote

Key Management of Madrigal Pharmaceuticals Inc

Name

Title

Ms. Mardi C. Dier

Executive VP & CFO

Ms. Shannon Kelley

Executive VP, Chief Legal Officer & Corporate Secretary

Mr. Mark Underwood

Executive Vice President of Business Planning & Operations

Mr. Clint Wallace

Executive VP & Chief Human Resources Officer

Mr. William J. Sibold

CEO, President & Director

Dr. Rebecca A. Taub M.D.

Founder, Senior Scientific & Medical Advisor and Director

Ms. Carole Huntsman

Executive VP & Chief Commercial Officer

Ms. Rita Thakkar

Senior VP & Chief Accounting Officer

Mr. Ronald Filippo

Executive VP & Chief Information Officer

Ms. Tina E. Ventura

Chief Investor Relations Officer

FAQs

What is Madrigal Pharmaceuticals Inc share price today?

Madrigal Pharmaceuticals Inc share price today is $513.66 as on at the close of the market. Madrigal Pharmaceuticals Inc share today touched a day high of $520.77 and a low of $504.

What is the 52 week high and 52 week low for Madrigal Pharmaceuticals Inc share?

Madrigal Pharmaceuticals Inc share touched a 52 week high of $615 on and a 52 week low of $265 on . Madrigal Pharmaceuticals Inc stock price today i.e. is closed at $513.66,which is 16.48% down from its 52 week high and 93.83% up from its 52 week low.

What is Madrigal Pharmaceuticals Inc's market capitalisation today?

Madrigal Pharmaceuticals Inc market capitalisation is $0.01T as on .

How to invest in Madrigal Pharmaceuticals Inc Stock (MDGL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Madrigal Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Madrigal Pharmaceuticals Inc Shares that will get you 0.0029 shares as per Madrigal Pharmaceuticals Inc share price of $513.66 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Madrigal Pharmaceuticals Inc Stock (MDGL) from India?

Indian investors can start investing in Madrigal Pharmaceuticals Inc (MDGL) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Madrigal Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Madrigal Pharmaceuticals Inc share’s latest price of $513.66 as on May 2, 2026 at 1:29 am IST, you will get 0.0195 shares of Madrigal Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Madrigal Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Madrigal Pharmaceuticals Inc stock has given 277.46% share price returns and 28.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?